Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.
Pfizer
Pfizer
Brown University
Brown University
Columbia University
Infinity Pharmaceuticals, Inc.
Children's Oncology Group